Drugs for Migraine Prophylaxis

This medical review examines current pharmacological strategies for migraine prophylaxis, distinguishing between episodic and chronic forms of the condition. The authors evaluate traditional oral therapies such as beta-blockers, topiramate, and amitriptyline, noting that while effective for episodic cases, they often carry significant side effects. A major focus is placed on recent therapeutic advancements, specifically monoclonal antibodies and gepants that target the CGRP pathway. These newer treatments demonstrate high tolerability and effectiveness, even for patients suffering from medication overuse headache or those who failed previous therapies. Additionally, onabotulinumtoxinA is highlighted as a proven option specifically for chronic migraine management. The text concludes that these modern interventions offer a superior safety profile and rapid onset of action compared to conventional medications.